1999
DOI: 10.1001/archderm.135.10.1255
|View full text |Cite
|
Sign up to set email alerts
|

Mohs Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(12 citation statements)
references
References 41 publications
0
12
0
Order By: Relevance
“…The minimum important difference in recurrence rates between therapies has not been established (Shuster, 1999), although some have acknowledged that a difference in recurrence rates of 4% might be considered clinically unimportant (McGovern and Leffell, 1999). We detected a difference between excision and Mohs surgery of 1.4% [−0.5, 3.5], and suggest that because the confidence limits exclude 4%, our results indicate that the treatments did not differ significantly in preventing recurrence in our practice settings.…”
Section: Discussionmentioning
confidence: 99%
“…The minimum important difference in recurrence rates between therapies has not been established (Shuster, 1999), although some have acknowledged that a difference in recurrence rates of 4% might be considered clinically unimportant (McGovern and Leffell, 1999). We detected a difference between excision and Mohs surgery of 1.4% [−0.5, 3.5], and suggest that because the confidence limits exclude 4%, our results indicate that the treatments did not differ significantly in preventing recurrence in our practice settings.…”
Section: Discussionmentioning
confidence: 99%
“… Recurrence rates following excision using the Mohs' microscopically controlled technique for the treatment of recurrent basal cell carcinoma range from 3.4 to 7.3% 4,39–44 …”
Section: Discussionmentioning
confidence: 99%
“…5 It is widely accepted that MMS is the most effective current method for removal of aggressive BCC in terms of compromise between maximum conservation of healthy skin and minimum recurrence rates. [6][7][8] While 5-yr recurrence rates for BCC treated by MMS are 1.4% for primary tumors and 4% for recurrent tumors, 9 for standard excision, this rate reaches 3.2 to 10% for primary tumors, and more than 17% for recurrent BCCs. 10 It has also been reported that at shorter follow-up periods ͑18 months͒, MMS was considerably more advantageous than surgical excision especially for recurrent tumors 7 ͑recurrence rate 0 versus 3%͒.…”
Section: Introductionmentioning
confidence: 99%